MeiraGTx Holdings (MGTX) Total Liabilities (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Total Liabilities came in at $250.2 million in Q4 2025, up 23.92% YoY from $201.9 million in Q4 2024, and up 8.78% on a QoQ basis from $230.0 million in Q3 2025.
MeiraGTx Holdings (MGTX) Total Liabilities (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Total Liabilities data on file, last reported at $250.2 million in Q4 2025.
- Quarterly Total Liabilities rose 23.92% year-over-year to $250.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $250.2 million (up 23.92% YoY) and the FY2025 annual result came in at $250.2 million, up 23.92% from the prior year.
- Total Liabilities improved to $250.2 million in Q4 2025, from $230.0 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $250.2 million in Q4 2025 to a low of $110.5 million in Q2 2022.
- A 5-year average of $175.1 million and a median of $187.1 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities decreased 8.72% — and 2023, when it soared 69.01%.
- Tracing MGTX's Total Liabilities over 5 years: stood at $134.8 million in 2021, then jumped by 48.78% to $200.5 million in 2022, then dropped by 5.95% to $188.6 million in 2023, then rose by 7.08% to $201.9 million in 2024, then advanced by 23.92% to $250.2 million in 2025.
- The last three Total Liabilities figures came in at $250.2 million (Q4 2025), $230.0 million (Q3 2025), and $195.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 250.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 250.22 Mn |
| Sep 30, 2025 | 230.03 Mn |
| Jun 30, 2025 | 195.76 Mn |
| Mar 31, 2025 | 190.92 Mn |
| Dec 31, 2024 | 201.92 Mn |
| Sep 30, 2024 | 203.75 Mn |
| Jun 30, 2024 | 186.61 Mn |
| Mar 31, 2024 | 187.50 Mn |
| Dec 31, 2023 | 188.57 Mn |
| Sep 30, 2023 | 175.31 Mn |
| Jun 30, 2023 | 186.74 Mn |
| Mar 31, 2023 | 197.92 Mn |
| Dec 31, 2022 | 200.50 Mn |
| Sep 30, 2022 | 178.74 Mn |
| Jun 30, 2022 | 110.49 Mn |
| Mar 31, 2022 | 126.41 Mn |
| Dec 31, 2021 | 134.76 Mn |
| Sep 30, 2021 | 115.50 Mn |
| Jun 30, 2021 | 121.05 Mn |
| Mar 31, 2021 | 118.88 Mn |